Elkhorn Investments’s Colgate-Palmolive CL Stock Holding History

Elkhorn Investments’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-16,686	Closed	-$1.22M	–	100
2017 Q3	$1.22M	Sell	16,686 -743	-4%	-$53.5K	0.9%	74
2017 Q2	$1.25M	Sell	17,429 -1,203	-6%	-$89.3K	0.97%	48
2017 Q1	$1.36M	Buy	+18,632	New	+$1.3M	1.13%	13

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Elkhorn Investments's CL Position: Q4 2017 in Review

Elkhorn Investments sold out of Colgate-Palmolive (CL) in Q4 2017, closing a stake of 16,686 shares — an estimated $1.22M sold.

Elkhorn Investments first reported a position in CL in Q1 2017 and held it in 3 quarters. The position peaked at $1.36M in Q1 2017. 1,474 funds tracked by Wall St. Rank hold CL as of Q4 2017.

Elkhorn Investments reported no remaining Colgate-Palmolive position as of Q4 2017 after selling out during the quarter.
Elkhorn Investments sold 16,686 Colgate-Palmolive shares in Q4 2017, an estimated $1.22M.
Elkhorn Investments first reported a position in Colgate-Palmolive in Q1 2017 and held it in 3 quarters.
Elkhorn Investments's Colgate-Palmolive position peaked at $1.36M in Q1 2017.
1,474 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2017.

Based on Elkhorn Investments's 13F filing for Q4 2017, filed 14 Feb 2018.